You are currently browsing the category archive for the ‘STRONG signal’ category.

Just as the central banks are ramping up the printing presses, and De La Rue (DLAR, 948p) declare a ‘strong order book’ and ‘operating cashflow remains strong’ in their pre close statement on September 16th, the CEO Leo Quinn and CFO Stephen King reduce their holdings substantially.
The statement reads fairly positively, but the one thing missing is any comment on costs. Maybe those haven’t been added up yet.
Stephen King, CFO, on September 18th sold 36907 shares at 920p, raising GBP 340k. These are the balance of the shares he exercised in July, having sold about 25,000 to pay the tax due. He is left with 46620 shares.
Leo Quinn, CEO, on September 19th sold 78500 shares at 948p, raising GBP 740k. This leaves him with 126,000 shares.
De la Rue looks to be ‘up with events’, having outperformed the FTSE 250 by 50% in the last year. I think King and Quinn might have a point here.
Value of directors dealings as a signal for investors: STRONG.
It seems to me as if Savills (SVS, 266p) are almost a second derivative on the UK housing market. Not only are there huge swings in sentiment on housing, but these seem to play out with greater amplitude in the Savills share price.
Of course Lehmans demise will impact the London housing market. Not only by Lehman redundancies, but also having all those other banks not paying bonuses for a couple of years: ‘you’re lucky to have a job, son’.
Savills directors dealings seem to be a pretty good indicator (or maybe influence) on the share price.
Simon Hope on Friday sold 62283 shares at 295p, taking his holding to 87,547 shares.
I’ve commented on him before (links to comments in blue), so let’s look at how the share price coincides with Directors activity in the sector, and my comments:
November 8th 2007: Hope sold GBP 350k (net of options exercise) of shares at 353p. I said Housebuilders- too early to buy.
March 10th 2008. I highlighted the ‘risk’ inherent in Savills shares ahead of results, using Hopes share sale in November as an indicator, by saying Savills up 50% this year, results Wednesday. Watch out.
August 4th 2008. We saw directors (Sir John Ritblat and CEO Izett) buying at Colliers Re, also in the agency/property management sector. As a result I said Real Estate agents – time to buy?
Now let’s look at the value of using these directors dealings as a signal for investors. I list here the dates of my comments, and the share price performance between them:
November 8th to March 10th SVS down 5%
March 10th to August 4th, SVS down 35% absolute, or down 13% relative to the FTSE 250.
August 4th to September 12th, SVS up 33% absolute, or 32% relative, but Hope didn’t announce his sale until yesterday, so
August 4th to September 15th, SVS up 23% absolute, or up 25% relative.
So what is the downside risk in Savills today then, and can this string of successful calls be repeated?
Between August 4th and today, Savills are up roughly 30% relative to Colliers Re. If you look at a longer term chart of these two stocks, they more or less perform in line with each other. Colliers is a little slower to move due to its illiquidity. So that’s what I think the scale of the downside risk is in Savills.
Also note that Savills have a pretty heavy cost base with 17,000 employees, versus Lehmans 28,000.
Value of Directors Dealings as a signal to investors: STRONG
Link to all my previous comments on Savills here.
Over a tense weekend for the 25,000 employees of Lehman, praying for a rescue package, I spot further director selling at Hargreaves Lansdown (HL., 191p).
On September 9th we saw the CFO Martin Mulligan and his Accounting colleague Tracy Taylor selling down less than 10% of their holdings.
On September 11th the Group Compliance Director Nigel Bence sold almost a third of his holdings, selling just over 250,000 shares held in his and his wifes name, to leave them with 561,207 shares.
HL were up more than 50% from their low. With equity trading volumes falling and the US heading for months of financial turmoil as a fallout from the (likely) collapse of Lehman (FT comment), I consider the risks lie substantially on the downside, and suspect Bence, Mulligan and Taylor would agree with me. As management concluded in their results presentation last week: ‘Volatility will impact profit growth’. That volatility is not yet receding.
For my last comment on Hargreaves Lansdown of September 12th ‘Volatility will impact profit growth’ see here.
With a third director selling, I now consider the value of the ‘signal’ from directors dealings to be STRONG.
Addendum Sept 24:
Further selling by CFO Martin Mulligan (sold 142k shares at 202p 19/9) and Head of Group Accounting Tracy Taylor (sold 30k shares at 200p-204p 22/9) reinforce the signal on Hargreaves Lansdown.
It was announced yesterday that John Juric, a PDMR [senior manager] of Fiberweb (FWEB, 52p), had on September 8th invested GBP 52,000 by buying 100,000 shares at between 52p and 52.2p.
This led me to review recent director buying at Fiberweb. Directors of the group have trebled their positions in Fiberweb by buying over 1.2 million shares in the last four months, at prices between 43p and 45.6p.
Fiberweb was spun off from BBA Group in late 2006, initially trading at 167p before moving to a high of 226p in February 2007. It wasn’t until the share price had retreated to 56p in October 2007 that a majority of directors started to buy.
I have suggested in past comments that these ‘signals’ from directors buying remind me of Enodis and EMAP, where, following a collapse in takeover talks, directors aggressively bought shares in their own company.
Signal strength for director dealing activity in Fiberweb remains ‘STRONG’
For my previous comments on Fiberweb ‘Directors buying, cost cutting, possible takeover target’, and ‘Directors pile in after takeover talks collapse’ click link here.
To access a Reuters profile of Fiberweb see here.
Enodis commentary here.
EMAP commentary here.
Disclosure: I have a position in Fiberweb.
I remember fondly my Haynes manual, covered in grease and brake fluid, and an absolute necessity in my dire attempts to reassemble my sky blue Triumph Herald after my earlier overenthusiastic exploratory activity.

So I’ve taken a look at recent directors dealings in Haynes (HYNS, 178.5p), despite its very limited size (£13m mkt cap).
Chairman John Haynes on Thursday bought 35,000 shares (including 20,000 in his wifes name) at 170p, up 30p from the previous days close due to enthusiastically received results. Haynes now holds 130,000 shares.
Chief Executive Eric Oakley bought 20,000 shares at 165p, taking his holding to 43,000 shares.
I believe these purchases to be significant:
1. They are an increase in existing holding of 35% and 90% respectively.
2. They are the first purchases by Haynes directors in almost SIX years. Also worth noting is that Director MEF Haynes last sold shares at 378p in March ’05, and John Haynes last sold in October ’03 at 313p.
I believe the Signal Strength implied by the directors purchase activity merits a STRONG rating.

Three directors of Serica Energy (SQZ, 69.5p) have been buying shares.
Serica Energy (link to company website) announced on Friday August 15th that:
Anthony Walker, Non Exec Chairman, bought 360,000 shares at 69p to increase his position to 5.6m shares,
Paul Ellis, CEO, boughtt 200,000 shares at 69p, to take his holding to 650,000 shares, and
Christopher Hearne, CFO, bought 75,000 shares at 69p to take his holding in Serica Energy to 675,000 shares.
Between them they have invested £440k.
In March 2008 directors Ellis and Cartwright bought shares at between 71p and 83p. Subsequently the shares reached a recent high of 108p in May. They then only bought 110,000 shares between them.
I consider Fridays purchases to be more significant as three directors are buying, investing significant amounts, and increasing their positions by an average of 20%. Signal strength: STRONG
The three Executive Directors of Medicsight (MDST, 46p), an AIM listed company, have announced today their maiden share purchase since the group was listed in June last year at 110p.
‘On 11 August 2008, Executive Directors Tim Paterson-Brown, David Sumner and Allan Rowley collectively purchased 310,500 ordinary shares of the Company at an average price of 42 pence per share.’
None of these executive directors was previously a holder of Medicsight shares, though Paterson-Brown was reported to hold a 5% stake in Medicsights majority shareholder MGT Capital Investments (Medicsight 2007 Annual Report). They also own options over between 1 million and 1 3/4 million shares each exercisable between 50p and 110p. For details see the 2007 Annual Report.
Even though the $$ investment per director is under £50k, I consider this move by the three executive directors to be significant.
STRONG signal
Disclosure: I have a position in Medicsight shares.
Carnival yesterday August 11th announced further director selling. I believe this to be a significant negative indicator. Please go to this post for full details.



